North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity
North America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 25 tables and 44 figures, this 107-page report “North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
HSV-1
HSV-2
Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Acyclovir
Valacyclovir
Famciclovir
Other Drugs
By Route of Administration, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Oral
Topical
Injection
By Patient Gender, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Female
Male
By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 25 tables and 44 figures, this 107-page report “North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
HSV-1
HSV-2
Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Acyclovir
Valacyclovir
Famciclovir
Other Drugs
By Route of Administration, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Oral
Topical
Injection
By Patient Gender, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Female
Male
By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY VIRUS TYPE
3.1 Market Overview by Virus Type
3.2 HSV-1
3.3 HSV-2
4 SEGMENTATION OF NORTH AMERICA MARKET BY DRUG TYPE
4.1 Market Overview by Drug Type
4.2 Acyclovir
4.3 Valacyclovir
4.4 Famciclovir
4.5 Other Drugs
5 SEGMENTATION OF NORTH AMERICA MARKET BY ROUTE OF ADMINISTRATION
5.1 Market Overview by Route of Administration
5.2 Oral
5.3 Topical
5.4 Injection
6 SEGMENTATION OF NORTH AMERICA MARKET BY PATIENT GENDER
6.1 Market Overview by Patient Gender
6.2 Female
6.3 Male
7 SEGMENTATION OF NORTH AMERICA MARKET BY DISTRIBUTION CHANNEL
7.1 Market Overview by Distribution Channel
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies
7.5 Drug Stores
8 NORTH AMERICA MARKET 2022-2032 BY COUNTRY
8.1 Overview of North America Market
8.2 U.S.
8.3 Canada
8.4 Mexico
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF NORTH AMERICA MARKET BY VIRUS TYPE
3.1 Market Overview by Virus Type
3.2 HSV-1
3.3 HSV-2
4 SEGMENTATION OF NORTH AMERICA MARKET BY DRUG TYPE
4.1 Market Overview by Drug Type
4.2 Acyclovir
4.3 Valacyclovir
4.4 Famciclovir
4.5 Other Drugs
5 SEGMENTATION OF NORTH AMERICA MARKET BY ROUTE OF ADMINISTRATION
5.1 Market Overview by Route of Administration
5.2 Oral
5.3 Topical
5.4 Injection
6 SEGMENTATION OF NORTH AMERICA MARKET BY PATIENT GENDER
6.1 Market Overview by Patient Gender
6.2 Female
6.3 Male
7 SEGMENTATION OF NORTH AMERICA MARKET BY DISTRIBUTION CHANNEL
7.1 Market Overview by Distribution Channel
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies
7.5 Drug Stores
8 NORTH AMERICA MARKET 2022-2032 BY COUNTRY
8.1 Overview of North America Market
8.2 U.S.
8.3 Canada
8.4 Mexico
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
RELATED REPORTS
LIST OF TABLES:
Table 1. Snapshot of North America Genital Herpes Treatment Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in North America Genital Herpes Treatment Market
Table 6. North America Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 7. North America Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 8. Side Effects of Genital Herpes Medications
Table 9. Vaccine Pipelines for Herpes
Table 10. North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn
Table 11. North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn
Table 12. North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 13. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn
Table 14. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 15. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 16. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 17. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 18. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 19. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 20. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 21. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 22. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 23. Abbott: Company Snapshot
Table 24. Abbott: Business Segmentation
Table 25. Abbott: Product Portfolio
Table 1. Snapshot of North America Genital Herpes Treatment Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in North America Genital Herpes Treatment Market
Table 6. North America Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 7. North America Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 8. Side Effects of Genital Herpes Medications
Table 9. Vaccine Pipelines for Herpes
Table 10. North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn
Table 11. North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn
Table 12. North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 13. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn
Table 14. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 15. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 16. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 17. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 18. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 19. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 20. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 21. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 22. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 23. Abbott: Company Snapshot
Table 24. Abbott: Business Segmentation
Table 25. Abbott: Product Portfolio
LIST OF FIGURES:
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. North America Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Genital Herpes Treatment Market
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 8. Primary Restraints and Impact Factors of North America Genital Herpes Treatment Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of North America Genital Herpes Treatment Market
Figure 11. Breakdown of North America Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue
Figure 12. North America Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)
Figure 13. North America Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn
Figure 14. North America Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn
Figure 15. Breakdown of North America Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue
Figure 16. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 17. North America Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn
Figure 18. North America Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn
Figure 19. North America Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn
Figure 20. North America Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn
Figure 21. Breakdown of North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue
Figure 22. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 23. North America Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn
Figure 24. North America Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn
Figure 25. North America Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn
Figure 26. Breakdown of North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue
Figure 27. North America Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)
Figure 28. North America Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn
Figure 29. North America Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn
Figure 30. Breakdown of North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue
Figure 31. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 32. North America Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn
Figure 33. North America Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn
Figure 34. North America Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn
Figure 35. North America Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn
Figure 36. Breakdown of North America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue
Figure 37. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 38. Percentage of LGBT in Total Population in U.S., 2012-2021
Figure 39. Estimated Number of New (Incident) and Existing (Prevalent) Sexually Transmitted Infections in U.S. in 2018
Figure 40. Healthcare Cost by STI Type in U.S. in 2018
Figure 41. U.S. Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 42. Canada Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 43. Genital Herpes Treatment Market in Mexico, 2022-2032, $ mn
Figure 44. Growth Stage of North America Genital Herpes Treatment Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. North America Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Genital Herpes Treatment Market
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 8. Primary Restraints and Impact Factors of North America Genital Herpes Treatment Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of North America Genital Herpes Treatment Market
Figure 11. Breakdown of North America Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue
Figure 12. North America Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)
Figure 13. North America Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn
Figure 14. North America Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn
Figure 15. Breakdown of North America Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue
Figure 16. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 17. North America Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn
Figure 18. North America Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn
Figure 19. North America Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn
Figure 20. North America Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn
Figure 21. Breakdown of North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue
Figure 22. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 23. North America Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn
Figure 24. North America Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn
Figure 25. North America Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn
Figure 26. Breakdown of North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue
Figure 27. North America Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)
Figure 28. North America Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn
Figure 29. North America Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn
Figure 30. Breakdown of North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue
Figure 31. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 32. North America Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn
Figure 33. North America Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn
Figure 34. North America Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn
Figure 35. North America Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn
Figure 36. Breakdown of North America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue
Figure 37. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 38. Percentage of LGBT in Total Population in U.S., 2012-2021
Figure 39. Estimated Number of New (Incident) and Existing (Prevalent) Sexually Transmitted Infections in U.S. in 2018
Figure 40. Healthcare Cost by STI Type in U.S. in 2018
Figure 41. U.S. Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 42. Canada Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 43. Genital Herpes Treatment Market in Mexico, 2022-2032, $ mn
Figure 44. Growth Stage of North America Genital Herpes Treatment Industry over the Forecast Period
